Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.
Department of Orthopaedics, Dartmouth Health, Lebanon, NH, USA.
Ann Surg Oncol. 2023 Jul;30(7):4097-4108. doi: 10.1245/s10434-023-13364-z. Epub 2023 Apr 11.
Breast-conserving surgery (BCS) is an integral component of early-stage breast cancer treatment, but costly reexcision procedures are common due to the high prevalence of cancer-positive margins on primary resections. A need exists to develop and evaluate improved methods of margin assessment to detect positive margins intraoperatively.
A prospective trial was conducted through which micro-computed tomography (micro-CT) with radiological interpretation by three independent readers was evaluated for BCS margin assessment. Results were compared to standard-of-care intraoperative margin assessment (i.e., specimen palpation and radiography [abbreviated SIA]) for detecting cancer-positive margins.
Six hundred margins from 100 patients were analyzed. Twenty-one margins in 14 patients were pathologically positive. On analysis at the specimen-level, SIA yielded a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 42.9%, 76.7%, 23.1%, and 89.2%, respectively. SIA correctly identified six of 14 margin-positive cases with a 23.5% false positive rate (FPR). Micro-CT readers achieved sensitivity, specificity, PPV, and NPV ranges of 35.7-50.0%, 55.8-68.6%, 15.6-15.8%, and 86.8-87.3%, respectively. Micro-CT readers correctly identified five to seven of 14 margin-positive cases with an FPR range of 31.4-44.2%. If micro-CT scanning had been combined with SIA, up to three additional margin-positive specimens would have been identified.
Micro-CT identified a similar proportion of margin-positive cases as standard specimen palpation and radiography, but due to difficulty distinguishing between radiodense fibroglandular tissue and cancer, resulted in a higher proportion of false positive margin assessments.
保乳手术(BCS)是早期乳腺癌治疗的一个组成部分,但由于初次切除的阳性切缘率较高,昂贵的再次切除术很常见。因此,需要开发和评估改进的切缘评估方法,以便在术中检测阳性切缘。
通过前瞻性试验,评估了微计算机断层扫描(micro-CT)结合三位独立读者的放射学解读在 BCS 切缘评估中的作用。结果与标准的术中切缘评估(即标本触诊和放射照相术,简称 SIA)进行了比较,以检测阳性切缘。
100 名患者的 600 个切缘进行了分析。14 名患者的 21 个切缘病理阳性。在标本水平分析中,SIA 的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为 42.9%、76.7%、23.1%和 89.2%。SIA 正确识别了 14 个切缘阳性病例中的 6 个,假阳性率(FPR)为 23.5%。micro-CT 读者的敏感性、特异性、PPV 和 NPV 范围分别为 35.7-50.0%、55.8-68.6%、15.6-15.8%和 86.8-87.3%。micro-CT 读者正确识别了 14 个切缘阳性病例中的 5-7 个,FPR 范围为 31.4-44.2%。如果 micro-CT 扫描与 SIA 相结合,最多可以识别出三个额外的阳性切缘标本。
micro-CT 识别出的阳性切缘病例与标准的标本触诊和放射照相术相似,但由于难以区分致密的纤维腺体组织和癌症,导致更多的假阳性切缘评估。